aurora is a canadian company and licensed producer of artisanal medical marijuana pursuant to the marihuana for medical purposes regulations. we ensure the highest quality, reliability, and safety of our products through advanced cultivation techniques carried out in our 55,200 square foot expandable state-of-the-art production facility in alberta, canada. aurora’s wholly-owned subsidiary, australis capital inc., seeks to be an active participant in the u.s. cannabis market.
Company profile
Ticker
ACB
Exchange
Website
CEO
Michael Singer
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
SEC CIK
Corporate docs
ACB stock data
Latest filings (excl ownership)
6-K
Aurora Cannabis Announces CFO Transition and Completion of Previously Announced Share Consolidation
20 Feb 24
6-K
Material Change Report
16 Feb 24
6-K
Aurora Cannabis Announces Fiscal 2024 Third Quarter Results; Generates Record Adjusted EBITDA of $4.3 Million
8 Feb 24
6-K
Condensed Consolidated Interim Financial Statements
8 Feb 24
6-K
Aurora Cannabis Acquires MedReleaf Australia
8 Feb 24
6-K
Aurora Cannabis Provides Business Update and Announces Date of Third Quarter Fiscal Year 2024 Investor Conference Call
31 Jan 24
6-K
Aurora Cannabis Announces Fiscal 2024 Second Quarter Results and Delivers Record Positive Adjusted EBITDA
9 Nov 23
6-K
Condensed Consolidated Interim Financial Statements
9 Nov 23
6-K
Aurora Cannabis to Host Second Quarter Fiscal Year 2024 Investor Conference Call
27 Oct 23
6-K
Aurora Cannabis Inc. Announces Closing of its C$38.8 Million Bought Deal Financing, Including the Full Exercise of the Over-Allotment Option
3 Oct 23
Transcripts
ACB
Earnings call transcript
2023 Q1
11 Nov 22
ACB
Earnings call transcript
2022 Q4
21 Sep 22
ACB
Earnings call transcript
2022 Q3
13 May 22
ACB
Earnings call transcript
2022 Q2
11 Feb 22
ACB
Earnings call transcript
2021 Q1
10 Nov 21
ACB
Earnings call transcript
2021 Q4
28 Sep 21
ACB
Earnings call transcript
2021 Q3
14 May 21
ACB
Earnings call transcript
2021 Q2
12 Feb 21
ACB
Earnings call transcript
2021 Q1
9 Nov 20
Financial summary
Quarter (USD) | Mar 23 | Jun 22 | Jun 21 | Jun 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Mar 23 | Jun 22 | Jun 21 | Jun 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Institutional ownership, Q3 2023
84.7% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 211 |
Opened positions | 37 |
Closed positions | 25 |
Increased positions | 43 |
Reduced positions | 33 |
13F shares | Current |
---|---|
Total value | 16.83 bn |
Total shares | 46.21 mm |
Total puts | 942.80 k |
Total calls | 4.20 mm |
Total put/call ratio | 0.2 |
Largest owners | Shares | Value |
---|---|---|
CVI Investments | 15.78 mm | $0.00 |
MMCAP International Inc. SPC | 8.00 mm | $4.66 bn |
Renaissance Technologies | 6.36 mm | $3.71 bn |
Mirae Asset Global Investments | 2.89 mm | $1.69 bn |
Susquehanna International | 1.63 mm | $952.20 mm |
Millennium Management | 1.63 mm | $949.84 mm |
Yong Rong | 1.50 mm | $878.00 k |
MS Morgan Stanley | 1.14 mm | $669.52 mm |
AXS Investments | 1.13 mm | $659.51 mm |
Dimensional Fund Advisors | 862.92 k | $504.81 mm |
News
Bullish Monday For Marijuana Stocks - Greenlane Hldgs, Heritage Cannabis Holding Among Top Gainers
18 Mar 24
Why Science Applications International Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session
18 Mar 24
Cannabis Stock Movers For March 15, 2024
15 Mar 24
Cannabis Stocks Jump On News That DEA May Soon Undertake Marijuana Reform
15 Mar 24
Push To Postpone Cannabis Legalization In Germany, France Omits Medical Marijuana Flower & More Euro Weed Updates
14 Mar 24
Press releases
Aurora Introduces Medical Cannabis Pastilles for Patient Relief in Australia
4 Mar 24
Aurora Completes Final Repayment of Convertible Senior Notes Representing ~$465 Million in Total Repayments Since 2021; Cannabis Operations Are Now Debt Free[1]
29 Feb 24
Aurora Partners with Script Assist to Provide Better Access to UK Medical Cannabis
28 Feb 24
Thinking about buying stock in SoundHound AI, Lucid Group, Aurora Cannabis, Walmart, or CVS Health?
21 Feb 24
Aurora Cannabis Announces Fiscal 2024 Third Quarter Results; Generates Record Adjusted EBITDA of $4.3 Million
8 Feb 24